Joshua Philip Kesterson, MD
Gynecologic Oncology Physician · Newport, PA
Joshua Philip Kesterson, MD is a gynecologic oncology physician with a practice address in Newport, Pennsylvania, and NPI 1922142165, issued on Feb 19, 2007. Check the license (Pennsylvania MD443021, as entered in NPPES) on the Pennsylvania Department of State (PALS); the Medicare figures below come from public CMS files.
- Name
- Joshua Philip Kesterson
- Credential
- MD
- Primary taxonomy
- Gynecologic Oncology Physician 207VX0201X
- License numbers
- MD443021 PA
R0734 KY
245356 NY
Self-reported in NPPES; status is on the state search - Practice location
- 300 Bretz CT Ste 100, Newport, PA 17074
- Phone
- (717) 221-5940
- Enumerated
- Feb 19, 2007
- Record last updated
- Jun 18, 2024
- Fax
- (717) 233-1939
- Medicare enrollment
- Enrolled (PECOS I20110901000477); accepts Medicare assignment
- Medical or professional school
- University Of Missouri, Columbia School Of Medicine, 2003
- Entity
- Type 1 · individual
Also registered at 300 Bretz CT Ste 100
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Kendra Davis, MDFamily Medicine Physician1669433470
- Madhu Menon, MDFamily Medicine Physician1396706131
- Maureen Roberts, M.D.Obstetrics & Gynecology Physician1720422926
- Kelly Wolfkill, FNP-BCFamily Nurse Practitioner1124761986
Verify Joshua Philip Kesterson in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersPennsylvania Department of State (PALS)
Search for license MD443021Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
15% fewer Medicare Part D claims than the average gynecologic oncology physician in 2024
166 Medicare Part D claims for 44 beneficiaries, against an average of 195 among the 1,475 providers of this specialty who prescribed in Part D. Brand-name drugs were 10% of claims. 15 claims were for opioids.
Most prescribed
- Megestrol Acetate43 claims
- Letrozole16 claims
- Oxycodone Hcl13 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The practice group's MIPS final score for 2023 (Medicare payment program): 82.5 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $192,818.49
147 payments; by number, the most common kind was food and beverage; the largest payer was GlaxoSmithKline, LLC. The 1,199 providers of this specialty with any payment received $6,387.20 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through 2 group practices
- Pinnacle Health Medical ServicesNewport, PA
- Susquehanna Physician ServicesWilliamsport, PA
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
1 gynecologic oncology physician records list a practice address in Newport
They are 1 of the 71 NPPES records with a practice address in Newport, and 98 gynecologic oncology physician records in Pennsylvania.
Other gynecologic oncology physician records in Pennsylvania
- Nawar Abdul Latif, M.D.Philadelphia, PA1023247335
- Gazi Abdulhay, MDUpland, PA1548210024
- Allison Ball, M.D.Wilkes Barre, PA1205265972
- Jessica BergerPittsburgh, PA1679735864
- Cynthia Bergman, MDHorsham, PA1821062118
- Michelle BoisenPittsburgh, PA1700028818
- Richard Boulay, MDEaston, PA1013926922
- Shaina Bruce, M.D.Hershey, PA1952758914
- Tommy Buchanan, M.D.Willow Grove, PA1982992095
- Robert Burger, MDPhiladelphia, PA1043393564
Common questions
What is Joshua Philip Kesterson, MD's NPI number?
Joshua Philip Kesterson, MD's National Provider Identifier (NPI) is 1922142165, issued on Feb 19, 2007. An NPI identifies a provider in billing; it is not a license.
Where is Joshua Philip Kesterson, MD located?
The NPPES record lists a practice address at 300 Bretz CT Ste 100, Newport, PA, 17074. Phone: (717) 221-5940. Providers update this record themselves, so call before visiting.
How can I verify Joshua Philip Kesterson, MD's license?
NPPES lists Pennsylvania license number MD443021, as entered by the provider. Search the Pennsylvania Department of State (PALS) at https://www.pals.pa.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Joshua Philip Kesterson, MD prescribe under Medicare Part D?
In 2024, Joshua Philip Kesterson, MD had 166 Medicare Part D claims for 44 beneficiaries; the average among gynecologic oncology physician prescribers was 195. Part D covers Medicare prescriptions only.
What is Joshua Philip Kesterson, MD's MIPS final score?
The 2023 MIPS final score is 82.5 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.